• Something wrong with this record ?

The Parietal Atrophy Score on Brain Magnetic Resonance Imaging is a Reliable Visual Scale

D. Silhan, A. Bartos, J. Mrzilkova, O. Pashkovska, I. Ibrahim, J. Tintera

. 2020 ; 17 (6) : 534-539. [pub] -

Language English Country United Arab Emirates

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc23005006

AIMS: The purpose of the study was to evaluate the reliability of our new visual scale for a quick atrophy assessment of parietal lobes on brain Magnetic Resonance Imaging (MRI) among different professionals. A good agreement would justify its use for differential diagnosis of neurodegenerative dementias, especially early-onset Alzheimer's Disease (AD), in clinical settings. METHODS: The visual scale named the Parietal Atrophy Score (PAS) is based on a semi-quantitative assessment ranging from 0 (no atrophy) to 2 (prominent atrophy) in three parietal structures (sulcus cingularis posterior, precuneus, parietal gyri) on T1-weighted MRI coronal slices through the whole parietal lobes. We used kappa statistics to evaluate intra-rater and inter-rater agreement among four raters who independently scored parietal atrophy using PAS. Rater 1 was a neuroanatomist (JM), rater 2 was an expert in MRI acquisition and analysis (II), rater 3 was a medical student (OP) and rater 4 was a neurologist (DS) who evaluated parietal atrophy twice in a 3-month interval to assess intra-rater agreement. All raters evaluated the same 50 parietal lobes on brain MRI of 25 cognitively normal individuals with even distribution across all atrophy degrees from none to prominent according to the neurologist's rating. RESULTS: Intra-rater agreement was almost perfect with the kappa value of 0.90. Inter-rater agreement was moderate to substantial with kappa values ranging from 0.43-0.86. CONCLUSION: The Parietal Atrophy Score is the reliable visual scale among raters of different professions for a quick evaluation of parietal lobes on brain MRI within 1-2 minutes. We believe it could be used as an adjunct measure in differential diagnosis of dementias, especially early-onset AD.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23005006
003      
CZ-PrNML
005      
20230425171840.0
007      
ta
008      
230418s2020 ts f 000 0|eng||
009      
AR
024    7_
$a 10.2174/1567205017666200807193957 $2 doi
035    __
$a (PubMed)32851946
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ts
100    1_
$a Silhan, David $u Department of Neurology, Charles University, Third Faculty of Medicine, Prague, Czech Republic
245    14
$a The Parietal Atrophy Score on Brain Magnetic Resonance Imaging is a Reliable Visual Scale / $c D. Silhan, A. Bartos, J. Mrzilkova, O. Pashkovska, I. Ibrahim, J. Tintera
520    9_
$a AIMS: The purpose of the study was to evaluate the reliability of our new visual scale for a quick atrophy assessment of parietal lobes on brain Magnetic Resonance Imaging (MRI) among different professionals. A good agreement would justify its use for differential diagnosis of neurodegenerative dementias, especially early-onset Alzheimer's Disease (AD), in clinical settings. METHODS: The visual scale named the Parietal Atrophy Score (PAS) is based on a semi-quantitative assessment ranging from 0 (no atrophy) to 2 (prominent atrophy) in three parietal structures (sulcus cingularis posterior, precuneus, parietal gyri) on T1-weighted MRI coronal slices through the whole parietal lobes. We used kappa statistics to evaluate intra-rater and inter-rater agreement among four raters who independently scored parietal atrophy using PAS. Rater 1 was a neuroanatomist (JM), rater 2 was an expert in MRI acquisition and analysis (II), rater 3 was a medical student (OP) and rater 4 was a neurologist (DS) who evaluated parietal atrophy twice in a 3-month interval to assess intra-rater agreement. All raters evaluated the same 50 parietal lobes on brain MRI of 25 cognitively normal individuals with even distribution across all atrophy degrees from none to prominent according to the neurologist's rating. RESULTS: Intra-rater agreement was almost perfect with the kappa value of 0.90. Inter-rater agreement was moderate to substantial with kappa values ranging from 0.43-0.86. CONCLUSION: The Parietal Atrophy Score is the reliable visual scale among raters of different professions for a quick evaluation of parietal lobes on brain MRI within 1-2 minutes. We believe it could be used as an adjunct measure in differential diagnosis of dementias, especially early-onset AD.
650    _2
$a senioři $7 D000368
650    _2
$a atrofie $7 D001284
650    _2
$a mozek $x diagnostické zobrazování $x patologie $7 D001921
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a testy pro posouzení mentálních funkcí a demence $7 D000073216
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neurozobrazování $7 D059906
650    _2
$a odchylka pozorovatele $7 D015588
650    _2
$a temenní lalok $x diagnostické zobrazování $x patologie $7 D010296
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a vizuální analogová stupnice $7 D064232
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bartos, Ales $u Department of Neurology, Charles University, Third Faculty of Medicine, Prague, Czech Republic
700    1_
$a Mrzilkova, Jana $u Department of Anatomy, Charles University, Third Faculty of Medicine, Prague, Czech Republic
700    1_
$a Pashkovska, Olga $u Department of Neurology, Charles University, Third Faculty of Medicine, Prague, Czech Republic
700    1_
$a Ibrahim, Ibrahim $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Tintera, Jaroslav $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
773    0_
$w MED00008816 $t Current Alzheimer research $x 1875-5828 $g Roč. 17, č. 6 (2020), s. 534-539
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32851946 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425171836 $b ABA008
999    __
$a ok $b bmc $g 1925228 $s 1191215
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2020 $b 17 $c 6 $d 534-539 $e - $i 1875-5828 $m Current Alzheimer research $n Curr Alzheimer Res $x MED00008816
LZP    __
$a Pubmed-20230418

Find record

Citation metrics

Archiving options